Leaked figures show EU efforts to secure and export vaccines
-
EU-based firms shipped out 24.7m doses, and delivered over 50m to member states (Photo: European Commission)
EU states had exported 24.7 million does of coronavirus vaccines to 31 countries around the world as of 3 March, according to internal figures which came to light amid a row on "vaccine nationalism".
The UK was Europe's top export destination, receiving 8.1 million does, followed by Canada (3 million), Japan (2.7 million), Mexico (2.5 million), and Saudi Arabia (1 million).
Join EUobserver today
Become an expert on Europe
Get instant access to all articles — and 20 years of archives. 14-day free trial.
Choose your plan
... or subscribe as a group
Already a member?
Chile, Singapore, Malaysia, the US, and Australia also received over half-a-million doses each, according to a four-page European Commission document, dated 3 March, and seen by EUobserver.
The figures backed up EU Council president Charles Michel's recent claim that Europe was leading global efforts to curb the pandemic.
And they came in a nasty atmosphere, in which some UK politicians had accused Europe of hoarding the drugs for itself by trying to stop individual overseas shipments due to producers' failures to deliver on contractual obligations.
But at the same time, the figures showed disparities in vaccination rates in EU member states, which threatened to ignite public anger that vaccines were going abroad, even as Europe struggled to meet internal demand.
Malta (15.5), Denmark (10.6), and Cyprus (9.3) led the league table of total vaccinations (first and second jabs) administered so far per 100 members of countries' populations.
The majority of EU states were in the six-to-nine percent range, with an average of 7.8.
But some states were trailing far behind, with Latvia doing the worst (3.4), followed by Bulgaria (3.8), and Croatia (4.8).
The total number of doses delivered to EU countries stood at 51.4 million.
The main suppliers were pharmaceutical firms BioNTech/Pfizer, which had signed contracts for 600 million doses, followed by Moderna (460 million), CureVac (405 million), AstraZeneca (400 million), and Johnson & Johnson (400 million).
Sanofi also signed deals for 300 million, while contracts with Novavax (200 million) and Valneva (60 million) were still under negotiations.
Site Section
Related stories
- EU-UK vaccine 'nationalism' spat intensifies
- The Left: No more 'sorry', we want vaccine-fiasco inquiry
- Vaccine export 'ban' row heats up ahead of EU summit
- Von der Leyen doubles up on vaccine-donation pledge
- EU files: How to get them, how to leak them, and what's the point?
- EU against 'outright ban' of vaccine exports before summit